Arkolith/Insider Trading/JAZZ/Form 4

Henderson Mary Elizabeth

SVP, Technical OperationsJazz Pharmaceuticals plc (JAZZ) · full profile →Form 4 · filed Mar 2, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.0M
Net Open-Market Flow
-$1.0M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 26, 2026Grant(A)4K—$034K
Feb 26, 2026Sell(S)5K$194.49$1.0M29K

Transaction Codes

A
Grant / award
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001989533-26-000006) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML